Please assess the completion status of the following clinical trial:

Trial Title: A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and/or Females of non-childbearing potential between 18 and 70 years of age~2. History of mild to moderate hypertension~Exclusion Criteria:~1. Type 1 or 2 diabetes on prescribed medications~2. Secondary, severe, or malignant hypertension~3. History of a significant cardiovascular event within the last 12 months of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- PF-00489791 20 mg titrated to 40 mg (Type: EXPERIMENTAL): None
- PF-00489791 4 mg (Type: EXPERIMENTAL): None
- PF-00489791 10 mg (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).